News

Wednesday January 30, 2019

30 Jan 2019 – Neil Clark, CEO, interviewed at Proactive Investor event on 28 Janua...

Please follow link below to watch Proactive Investor interview: Neil Clark, CEO, interviewed at Proactive Investor event on 28 January 2019

Monday January 28, 2019

28 Jan 2019 – Second positive Phase 1 trial data for XF-73

Please click on link below for Destiny Pharma press release: Second positive phase 1 trial data for XF-73

Friday January 25, 2019

25 Jan 2019 – Destiny awarded new UK-China AMR grant

New grant awarded under UK-China AMR programme

Thursday January 24, 2019

24 Jan 2019 – Destiny Pharma notes UK 5-year action plan on AMR

Destiny Pharma notes UK 5-year action plan on AMR